Skip to content

Remote Assessment of Outpatient With Severe Acute Respiratory Syndrome (SARS-CoV-2)

Remote Assessment of Outpatient With SARS-CoV-2

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05125887
Acronym
EVIDENCE
Enrollment
92
Registered
2021-11-18
Start date
2021-05-17
Completion date
2023-05-26
Last updated
2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV2 Infection

Brief summary

Outpatient management of patients with a milder form of COVID may be associated to an unfavorable initial or deferred course in relation to the pathology.. Outpatients represent the bulk of patients with COVID-19. To know their evolution, their secondary complications and identifying a profile of "at risk" patients is essential for the prevention and care of future non-hospitalized patients, in an epidemic context still active. This study could make it possible to redefine the follow-up of outpatients. The study consists of a simple questionnaire and possibly a teleconsultation.

Interventions

OTHERQuestionnaire

Patients diagnosed positive for COVID on an outpatient basis will respond to a questionnaire by mail, at 24 month of diagnosis. This questionnaire will make it possible in particular to collect intercurrent events (hospitalization, emergencies, etc.).

Sponsors

University Hospital, Limoges
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with a PCR (polymerase chain reaction assay ) positive for Sars-COV-2 between the start of the pandemic and May 11, 2020 * Outpatient care * Inclusion 24 months from the date of diagnosis of Sars-COV-2 (± 6 months)

Exclusion criteria

* Patients in EHPAD (accommodation facilities for dependent elderly people), home, retirement home, center for disabled people * Patients under protective measure, curators or guardianship * Patients with a pathology or condition that does not allow them to express their wishes * Patients hospitalized when performing PCR or within 10 days with Sars-COV-2

Design outcomes

Primary

MeasureTime frameDescription
Medical proceduresAt month 24number of medical procedures

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 27, 2026